Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Pazopanib in Treating Patients With Metastatic Urothelial Cancer
This study has been completed.
Study NCT00471536 Information provided by National Cancer Institute (NCI)
First Received on May 8, 2007. Last Updated on March 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anterior Urethral Cancer
Posterior Urethral Cancer
Recurrent Bladder Cancer
Recurrent Urethral Cancer
Stage IV Bladder Cancer
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Transitional Cell
Kidney Neoplasms
Ureteral Neoplasms
Urethral Neoplasms
Urinary Bladder Neoplasms
More general conditions related to this trial
Kidney Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Ureteral Diseases
Urethral Diseases
Urinary Bladder Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
pazopanib hydrochloride
pharmacological study
laboratory biomarker analysis
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
